These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 18367765

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Revised guidelines for management of steroid-sensitive nephrotic syndrome.
    Bagga A.
    Indian J Nephrol; 2008 Jan; 18(1):31-9. PubMed ID: 20368921
    [Abstract] [Full Text] [Related]

  • 3. Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing.
    Wu B, Mao J, Shen H, Fu H, Wang J, Liu A, Gu W, Shu Q, Du L.
    Nephrology (Carlton); 2015 Jan; 20(1):18-24. PubMed ID: 25312783
    [Abstract] [Full Text] [Related]

  • 4. Evaluation and management of steroid-sensitive nephrotic syndrome.
    Hodson EM, Alexander SI.
    Curr Opin Pediatr; 2008 Apr; 20(2):145-50. PubMed ID: 18332709
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Initial treatment of steroid-sensitive idiopathic nephrotic syndrome in children with mycophenolate mofetil versus prednisone: protocol for a randomised, controlled, multicentre trial (INTENT study).
    Ehren R, Benz MR, Doetsch J, Fichtner A, Gellermann J, Haffner D, Höcker B, Hoyer PF, Kästner B, Kemper MJ, Konrad M, Luntz S, Querfeld U, Sander A, Toenshoff B, Weber LT, Gesellschaft für Pädiatrische Nephrologie (GPN).
    BMJ Open; 2018 Oct 10; 8(10):e024882. PubMed ID: 30309995
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
    Sinha A, Puraswani M, Kalaivani M, Goyal P, Hari P, Bagga A.
    Kidney Int; 2019 Jan 10; 95(1):210-218. PubMed ID: 30497684
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Therapy: Maintenance of steroid-free remission in nephrotic syndrome.
    Deegens JK, Wetzels JF.
    Nat Rev Nephrol; 2015 Oct 10; 11(10):569-70. PubMed ID: 26195145
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of levamisole in steroid-dependent nephrotic syndrome.
    Madani A, Isfahani ST, Rahimzadeh N, Fereshtehnejad SM, Hoseini R, Moghtaderi M, Mohseni P, Ataiee N.
    Iran J Kidney Dis; 2010 Oct 10; 4(4):292-6. PubMed ID: 20852369
    [Abstract] [Full Text] [Related]

  • 16. Levamisole in Frequently-relapsing and Steroid-dependent Nephrotic Syndrome.
    Kiruba Samuel EM, Krishnamurthy S, Bhanudeep S, Muske S.
    Indian Pediatr; 2017 Oct 15; 54(10):831-834. PubMed ID: 28699616
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [The treatment with levamisole of frequently recurring steroid-sensitive idiopathic nephrotic syndrome in children].
    Kemper MJ, Amon O, Timmermann K, Altrogge H, Müller-Wiefel DE.
    Dtsch Med Wochenschr; 1998 Feb 27; 123(9):239-43. PubMed ID: 9524533
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.